Similarly, combining AFP with inflammatory markers like C-reactive protein or IL-6 may improve prognostic stratification by reflecting both tumor burden and systemic inflammation, which are critical drivers of HCC progression [23, 63, 64]. Here, AFP is linked to hepatocellular carcinoma.